Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Non-invasive brain stimulation to see if it changes pain avoidance in CRPS

Official title: Alpha tACS and Pain Avoidance Behavior in Chronic Pain Patients

Run by The Cleveland Clinic · NCT07791966 · Data updated 2026-11-12

This study tests whether a gentle brain stimulation method called tACS can change how people with complex regional pain syndrome avoid activities that might worsen their pain.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedAugust 31, 2028
Study endsDecember 2028
Registry record updatedAugust 28, 2026
Trial IDNCT07791966 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with CRPS type I or II, at least six months of refractory pain, daily pain of 5/10 or higher, and presence of allodynia and/or hyperalgesia.

Probably not a fit

Patients without CRPS-related pain avoidance patterns or those with exclusion criteria (e.g., pregnancy, major psychiatric disorders, or current neurostimulation therapy) may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses transcranial alternating current stimulation (tACS) to explore its effect on pain avoidance behavior in adults with CRPS. Participants are randomized to receive real alpha-frequency tACS (8-12 Hz) or a sham control, with the goal of determining if brain stimulation can modify avoidance of valued activities due to pain. The trial focuses on individuals with medically refractory CRPS for at least six months and moderate to severe daily pain, excluding those with concurrent neurostimulation devices or major psychiatric conditions. Primary outcomes examine changes in avoidance behavior, while secondary outcomes may include pain intensity and functional measures. The Cleveland Clinic leads the study with NCCIH collaboration, enrolling participants at the Cleveland Clinic site in Ohio.

Why it matters

Potential benefit: If successful, tACS could offer a non-invasive option to help CRPS patients engage more in daily activities by reducing pain-related avoidance.

How similar studies have gone: Previous research suggests brain stimulation can influence pain processing, but results for pain avoidance behavior specifically in CRPS are exploratory and not yet conclusive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Diagnosed with Complex Regional Pain Syndrome (CRPS) Type I or II, based on Budapest criteria
* 6 months or more of medically refractory severe pain
* Average daily pain for past 30 days \>= 5 on 0-10 scale
* Presence of allodynia and/or hyperalgesia
* Lower extremity CRPS: bilateral or unilateral pain
* Not concurrently treated with neurostimulation therapies such as spinal cord stimulators (SCS)
* Absence of co-occurring severe psychiatric disorders (PHQ-9\<19 and/or GAD-7\<14)

Exclusion Criteria:

* Age under 18 years, pregnant women of any age
* Any co-occurring pain diagnosis that might confound with allodynia/hyperalgesia resulting from CRPS reflecting a malfunction in sensory processing within the CNS.
* Less than six months of medically refractory pain
* Average daily pain for past 30 days \<5 on 0-10 scale
* Absence of allodynia and/or hyperalgesia
* Concurrent neurostimulation therapies such as SCS
* Severe disorders or conditions (e.g., cardiovascular, liver issues), terminal illness
* PHQ-9\>19 and/or GAD-7\>14 (severe depression/anxiety)

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.